The agreement demonstrates the key challenge for ADO and it's received the market reaction that should be expected. It can be interpreted in terms of it is going to take 5 years before the vaccine moves from testing and evaluation into production where volume should be much larger.
This will mean small sales volumes for at least the next 5 years. Imagine the number of Capital Raises that will be needed overt the next 5 years for ADO to keep going given their history of at least one raise per year as a core KPI.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $48.69M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.8¢ | $8.995K | 474.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 574697 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 400642 | 4 |
View Market Depth
| Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
| ADO (ASX) Chart |